Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Verona Pharma

    NASDAQ: VRNA · Real-Time Price · USD
    92.58
    0.38 (0.41%)
    At close: Jun 16, 2025, 3:59 PM
    94.00
    1.53%
    After-hours: Jun 16, 2025, 07:42 PM EDT

    Verona Pharma Statistics

    Share Statistics

    Verona Pharma has 84.98M shares outstanding. The number of shares has increased by 734.97% in one year.

    Shares Outstanding

    n/a
    		 84.98M

    Shares Change (YoY)

    n/a
    		 734.97%

    Shares Change (QoQ)

    n/a
    		 727.32%

    Owned by Institutions (%)

    n/a
    		 10.53%

    Shares Floating

    n/a
    		 76.56M

    Failed to Deliver (FTD) Shares

    n/a
    		 456

    FTD / Avg. Volume

    n/a
    		 0.03%

    Short Selling Information

    The latest short interest is 7.13M, so 8.39% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 7.13M

    Short % of Shares Out

    n/a
    		 8.39%

    Short % of Float

    n/a
    		 8.75%

    Short Ratio (days to cover)

    n/a
    		 5.43

    Valuation Ratios

    The PE ratio is -21.84 and the forward PE ratio is 106.34. Verona Pharma's PEG ratio is -0.11.

    PE Ratio

    n/a
    		 -21.84

    Forward PE

    n/a
    		 106.34

    PS Ratio

    n/a
    		 89.56

    Forward PS

    n/a
    		 5.4

    PB Ratio

    n/a
    		 18.51

    P/FCF Ratio

    n/a
    		 -30.84

    PEG Ratio

    n/a
    		 -0.11
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Verona Pharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 10.63, with a Debt / Equity ratio of 0.6.

    Current Ratio

    n/a
    		 10.63

    Quick Ratio

    n/a
    		 10.48

    Debt / Equity

    n/a
    		 0.6

    Debt / EBITDA

    n/a
    		 -0.86

    Debt / FCF

    n/a
    		 -1

    Interest Coverage

    n/a
    		 -6.57

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $202,291.87

    Profits Per Employee

    n/a
    		 $-829,751.2

    Employee Count

    n/a
    		 209

    Asset Turnover

    n/a
    		 0.09

    Inventory Turnover

    n/a
    		 0.41

    Taxes

    Income Tax

    n/a
    		 10.29M

    Effective Tax Rate

    n/a
    		 -6.31%

    Stock Price Statistics

    The stock price has increased by 508.65% in the last 52 weeks. The beta is 0.22, so Verona Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.22

    52-Week Price Change

    n/a
    		 508.65%

    50-Day Moving Average

    n/a
    		 70.58

    200-Day Moving Average

    n/a
    		 51.61

    Relative Strength Index (RSI)

    n/a
    		 78.04

    Average Volume (20 Days)

    n/a
    		 1,422,542

    Income Statement

    In the last 12 months, Verona Pharma had revenue of 42.28M and earned -173.42M in profits. Earnings per share was -2.16.

    Revenue

    n/a
    		 42.28M

    Gross Profit

    n/a
    		 39.7M

    Operating Income

    n/a
    		 -154.63M

    Net Income

    n/a
    		 -173.42M

    EBITDA

    n/a
    		 -142.19M

    EBIT

    n/a
    		 -139.59M

    Earnings Per Share (EPS)

    n/a
    		 -2.16
    Full Income Statement

    Balance Sheet

    The company has 399.76M in cash and 122.7M in debt, giving a net cash position of 277.06M.

    Cash & Cash Equivalents

    n/a
    		 399.76M

    Total Debt

    n/a
    		 122.7M

    Net Cash

    n/a
    		 277.06M

    Retained Earnings

    n/a
    		 -562.4M

    Total Assets

    n/a
    		 525.94M

    Working Capital

    n/a
    		 444.48M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -122.2M and capital expenditures 0, giving a free cash flow of -122.78M.

    Operating Cash Flow

    n/a
    		 -122.2M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -122.78M

    FCF Per Share

    n/a
    		 -0.19
    Full Cash Flow Statement

    Margins

    Gross margin is 93.89%, with operating and profit margins of -365.73% and -410.18%.

    Gross Margin

    n/a
    		 93.89%

    Operating Margin

    n/a
    		 -365.73%

    Pretax Margin

    n/a
    		 -385.84%

    Profit Margin

    n/a
    		 -410.18%

    EBITDA Margin

    n/a
    		 -336.31%

    EBIT Margin

    n/a
    		 -365.73%

    FCF Margin

    n/a
    		 -290.41%

    Dividends & Yields

    VRNA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for VRNA is $90, which is -2.3% lower than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $90

    Price Target Difference

    n/a
    		 -2.3%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 11.79

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist